Expression Vectors Market Size, Share, Segmentation, Trends, and Forecast 2028

Expression Vectors Market Size

The global Expression Vectors Market Size accrued earnings worth approximately 299 (USD Million) in 2021 and is predicted to gain revenue of about 571 (USD Million) by 2028, is set to record a CAGR of nearly 5.4% over the period from 2022 to 2028. The study provides assessment and analysis of the Expression Vectors Market on a global & regional level. It offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2021 along with a forecast from 2022 to 2028 based on revenue

Request Free Sample

Expression Vector Market: Outlook

Expression vector is also termed as expression constructs and is a kind of plasmid derivative that is devised for protein expression in cells. It has features such as replication origin, a selectable marker, and a particular location for gene insertion. Moreover, expression vector possess required elements including transcription termination sequence, strong promotion, and initiation sequence. Breakthroughs in protein expression and launching of new techniques in genetics, molecular biology, and genetic engineering domain will steer growth of expression vector industry.

The expression vector is also known as expression construct which is the basic tools in biotechnology for the production of proteins. E. coli is commonly used as the host for protein production. The expression vector is used in the production of insulin for medical treatments of diabetes. Virus vector, the bacterial vector, plasmid DNA and others are key types of vector system.

The major driving factor for the global expression vector market is the strong demand of protein-based drugs. Moreover, technological advancement in protein expression techniques, molecular biology, and bioinformatics is anticipated to drive the market demand in the years to come. Applications of expression vectors in the R&D of biomedical and biopharmaceutical products are expected to have the positive impact on expression vector market over the forecast period. However, high expenditure involved in research employing expression vectors may curb the market growth in the coming years. Nonetheless, large production of human insulin and other protein-based products that use expression vectors may open up new growth opportunities in the years to come.

Request Free Sample

Expression Vector Market: Growth Aspects

Genetic disorders, occurrence of lifestyle-related ailments, contagious diseases, and huge funding for biologics will steer the expansion of the expression vector industry. Additionally, breakthroughs in protein expression methods and launching of novel techniques in genetics, bioinformatics, and molecular biology domains will spur growth of expression vector market. Apart from this, unmet medical requirements owing to patent expiry of generic medicine will assist industry players in developing new drugs, thereby providing impetus to the expression vector business. However, huge cost of protein treatment and entry barriers as well as high market consolidation can create hindrances in growth path of expression vector market.

Furthermore, large-scale production of human insulin, as well as other protein-based products using expression vectors, will boost expression vectors market trends. Prominent use of expression vectors in research activities related to biomedical and biopharmaceutical products will enlarge scope of expression vectors market growth in upcoming years.

On the basis of the host, the market can be segmented into bacterial, yeast, insect and mammalian. Bacterial vector was accounted for the major share of total expression vectors market in 2019 and expected to exhibit significant share within the forecast period. This is mainly due to high transformation levels and simple transformation protocols. The mammalian expression vector is expected to witness the fastest growth within the forecast period. Mammalian host systems have the ability to carry out assembly of recombinant proteins, folding, and complex post-translational modifications.

The expression vectors market is segmented on the basis of different applications such as therapeutic, industrial, and research applications. Therapeutic has dominated the market with the largest share of the total market in 2019.  This growth is mainly attributed to the higher incidence rate of oncology diseases which can be treated by use of expression vectors. Research segment is also accounted for the significant share due to technological advancement in proteomics and novel product development.

Some of the key end-users in expression vectors market include biotechnology & pharmaceutical companies, contract research organizations (CROS) & contract manufacturing organizations (CMOS) & academic research institutes. Biotechnology & pharmaceutical was the leading segment with the largest number of market share of total revenue generated in 2019 owing to advancement in novel drug and protein pharmaceuticals synthesis using recombinant DNA technology. Contract research organizations (CROs) & contract manufacturing organizations (CMOs) is expected to witness significant growth in the years to come.

North America was the leading regional market for expression vectors in 2019 due to increasing scientific research and development of novel technologies. Moreover, high investment of the U.S. private companies in biology R&D activities further expected to boost the expression vectors market in North America. North America is followed by Asia-Pacific and Europe in terms of revenue. Asia Pacific is expected to exhibit strong growth for expression vectors in the years to come. This growth is mainly attributed to increasing penetration of companies in R&D activities in biotechnology perspective.

Expression Vector Market Report Scope:

Expression Vector Market: Regional Landscape

North America To Lead Regional Market Growth In 2022-2028

Growth of expression vector market in North America over forecast timespan is subject to rise in spending of U.S. based firms in biological research. Presence of giant players in Canada and the U.S. will contribute lucratively towards size of expression vectors market in North America.

Expression Vector Market: Competitive Insights

Key players profiled in the study and influencing the market growth are:

• Clontech Laboratories Inc.
• Merck Millipore
• New England Biolabs
• Promega Corporation
• Sigma-Aldrich Corporation
• Bio-Rad Laboratories
• Agilent Technologies
• QIAGEN
• GenScript USA Inc.

The global expression vectors market is segmented as follows:

By Host

• Bacterial
• Yeast
• Insect
• Mammalian 

By End User 

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
• Academic Research Institutes.

By Application 

• Therapeutic
• Industrial
• Research

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa